{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:12:11Z","timestamp":1791414731172,"version":"4.3.3"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.exppara.2013.09.015","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T21:39:06Z","timestamp":1380577146000},"page":"642-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil"],"prefix":"10.1016","volume":"135","author":[{"given":"J.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hoey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trudgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fairweather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2013.09.015_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0031182005007997","article-title":"Altered drug influx\/efflux and enhanced metabolic activity in triclabendazole \u2013 resistant liver flukes","volume":"131","author":"Alvarez","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156720106776359195","article-title":"Role of ABC transporters in veterinary drug research and parasite resistance","volume":"3","author":"Alvarez","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.exppara.2013.09.015_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.vetpar.2008.06.017","article-title":"Ketoconazole increases the plasma levels of ivermectin in sheep","volume":"157","author":"Alvinerie","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0020-7519(94)00105-W","article-title":"Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide","volume":"25","author":"Anderson","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0025","first-page":"290","article-title":"Effects of ivermectin and moxidectin on the transcription of genes coding for multidrug resistance associated proteins and behaviour in Caenorhabditis elegans","volume":"40","author":"Ardelli","year":"2008","journal-title":"J. Nematol."},{"key":"10.1016\/j.exppara.2013.09.015_b0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vetpar.2012.09.021","article-title":"Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin","volume":"191","author":"Ardelli","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1017\/S0031182009990345","article-title":"P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcinta and Haemonchus contortus","volume":"136","author":"Bartley","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.vetpar.2012.02.011","article-title":"Influence of Pluronic 85 and ketoconazole on disposition and efficacy of ivermectin in sheep infected with a multiple resistant Haemonchus contortus isolate","volume":"187","author":"Bartley","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.2042-7158.1996.tb03965.x","article-title":"Interaction between fenbendazole and piperonyl butoxide: pharmacokinetic and pharmacodynamic implications","volume":"48","author":"Benchaoui","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.exppara.2013.09.015_b0050","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/j.1460-2075.1995.tb07178.x","article-title":"A P-glycoprotein protects Caenorhabditis elegans against natural toxins","volume":"9","author":"Broeks","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2013.09.015_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0031182002002664","article-title":"Surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole (\u2018\u2018Valbazen\u201d)","volume":"126","author":"Buchanan","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/vr.148.23.723","article-title":"Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole \u2013 resistant Fasciola hepatica","volume":"148","author":"Coles","year":"2001","journal-title":"Vet. Rec."},{"key":"10.1016\/j.exppara.2013.09.015_b0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/vr.146.17.504-a","article-title":"The activity of closantel against adult triclabendazole \u2013 resistant Fasciola hepatica","volume":"146","author":"Coles","year":"2000","journal-title":"Vet. Rec."},{"key":"10.1016\/j.exppara.2013.09.015_b0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182008005222","article-title":"Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole \u2013 resistant isolate of Fasciola hepatica","volume":"136","author":"Devine","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0075","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1017\/S003118200999148X","article-title":"Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole","volume":"137","author":"Devine","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0080","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00436-010-1806-1","article-title":"Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole \u2013 resistant isolate of Fasciola hepatica","volume":"106","author":"Devine","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00436-010-1866-2","article-title":"Enhancement of the drug susceptibility of a triclabendazole \u2013 resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole","volume":"107","author":"Devine","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1017\/S0031182010001125","article-title":"Piperonyl butoxide enhances triclabendazole action against triclabendazole \u2013 resistant Fasciola hepatica","volume":"138","author":"Devine","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.vetpar.2010.12.002","article-title":"Enhancement of triclabendazole action in vivo against a triclabendazole \u2013 resistant isolate of Fasciola hepatica by co-treatment with ketoconazole","volume":"177","author":"Devine","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00436-011-2304-9","article-title":"Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole \u2013 resistant isolate of Fasciola hepatica","volume":"109","author":"Devine","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0105","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00436-011-2554-6","article-title":"Erratum to: Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole \u2013 resistant isolate of Fasciola hepatica","volume":"109","author":"Devine","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetpar.2011.08.006","article-title":"Potentiation of triclabendazole action in vivo against a triclabendazole \u2013 resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole","volume":"184","author":"Devine","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0304-4017(03)00008-6","article-title":"Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin","volume":"112","author":"Dupuy","year":"2003","journal-title":"Vet. Parasitol"},{"key":"10.1016\/j.exppara.2013.09.015_b0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-8703(85)90585-X","article-title":"The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans","volume":"109","author":"Echizen","year":"1985","journal-title":"Am. Heart J."},{"key":"10.1016\/j.exppara.2013.09.015_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2010.12.011","article-title":"Liver fluke isolates: a question of provenance","volume":"176","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetpar.2011.05.034","article-title":"Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?","volume":"180","author":"Fairweather","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0014-4894(86)90040-8","article-title":"Fasciola hepatica: tegumental changes induced in vivo by the deacetylated (amine) metabolite of diamphenethide","volume":"62","author":"Fairweather","year":"1986","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0140","series-title":"Fasciolosis","first-page":"47","article-title":"Development of Fasciola hepatica in the mammalian host","author":"Fairweather","year":"1999"},{"key":"10.1016\/j.exppara.2013.09.015_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.vetpar.2011.07.023","article-title":"Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept","volume":"183","author":"Fairweather","year":"2012","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetpar.2010.10.037","article-title":"Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica","volume":"176","author":"Flanagan","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vetpar.2010.10.057","article-title":"Comparison of two diagnostic assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep","volume":"176","author":"Flanagan","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetpar.2008.10.007","article-title":"The relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica","volume":"159","author":"Halferty","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0165","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1017\/S0031182009990643","article-title":"Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica","volume":"136","author":"Halferty","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.vetpar.2009.11.014","article-title":"Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, compound alpha","volume":"168","author":"Hanna","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2885.1987.tb00078.x","article-title":"The kinetics of triclabendazole disposition in sheep","volume":"10","author":"Hennessy","year":"1987","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.exppara.2013.09.015_b0180","unstructured":"Holmes, S.D., 1983. In vitro studies into the mode of action of anthelmintics on the liver fluke, Fasciola hepatica L. Ph.D Thesis, The Queen\u2019s University of Belfast."},{"key":"10.1016\/j.exppara.2013.09.015_b0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpara.2008.06.009","article-title":"Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans","volume":"39","author":"James","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.pt.2009.09.007","article-title":"An update on P-glycoprotein and drug resistance in Schistosoma mansoni","volume":"25","author":"James","year":"2009","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2011.03.004","article-title":"Pharmacology and potential physiological significance of schistosome multidrug resistance transporters","volume":"132","author":"Kasinathan","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molbiopara.2010.05.003","article-title":"Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel","volume":"173","author":"Kasinathan","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4267\/2042\/48095","article-title":"Efflux pump inhibitors: a progress in parasitic nematode control","volume":"164","author":"Kerboeuf","year":"2011","journal-title":"Bull. Acad. Vet. France"},{"key":"10.1016\/j.exppara.2013.09.015_b0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0924-8579(03)00221-8","article-title":"P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance","volume":"22","author":"Kerboeuf","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2013.09.015_b0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1018877803319","article-title":"Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein","volume":"16","author":"Kim","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-008-9833-2","article-title":"Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics","volume":"317","author":"Kumkate","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.exppara.2013.09.015_b0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pt.2008.03.011","article-title":"ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics","volume":"24","author":"Lespine","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0230","first-page":"58","article-title":"P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic resistance","volume":"2","author":"Lespine","year":"2012","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2013.09.015_b0235","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.vetpar.2010.04.039","article-title":"Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep","volume":"172","author":"Lifschitz","year":"2010","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.exppara.2010.01.009","article-title":"Cattle nematodes resistant to macrocyclic lactones: comparative effects of P-glycoprotein modulation on the efficacy and disposition kinetics of ivermectin and moxidectin","volume":"125","author":"Lifschitz","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0245","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2174\/138920112800399211","article-title":"Macrocyclic lactones and cellular transport\u2013related drug interactions: a perspective from in vitro assays to nematode control in the field","volume":"13","author":"Lifschitz","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.exppara.2013.09.015_b0250","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/j.1460-2075.1993.tb05806.x","article-title":"The expression of two P-glycoprotein (pgp) genes in transgenic Caenorhabditis elegans is confined to intestinal cells","volume":"12","author":"Lincke","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2013.09.015_b0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-4017(97)00177-5","article-title":"Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose regime","volume":"75","author":"L\u00f3pez-Garc\u00eda","year":"1998","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0031182006000114","article-title":"Adult triclabendazole resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha","volume":"133","author":"McConville","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0265","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00436-006-0270-4","article-title":"Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha","volume":"100","author":"McConville","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0270","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetpar.2008.01.022","article-title":"Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha","volume":"153","author":"McConville","year":"2008","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetpar.2009.02.004","article-title":"An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica","volume":"162","author":"McConville","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0280","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00436-009-1453-6","article-title":"Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha","volume":"105","author":"McConville","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0285","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S0031182009005678","article-title":"Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha","volume":"136","author":"McConville","year":"2009","journal-title":"Parasitology"},{"issue":"suppl A","key":"10.1016\/j.exppara.2013.09.015_b0290","first-page":"33","article-title":"The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep","volume":"78","author":"McCoy","year":"2005","journal-title":"Res. Vet. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0295","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00436-003-0930-6","article-title":"Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (\u201cTrodax\u201d)","volume":"91","author":"McKinstry","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0300","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00436-007-0564-1","article-title":"Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax)","volume":"101","author":"McKinstry","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0305","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00436-008-1241-8","article-title":"Morphological response of triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax)","volume":"104","author":"McKinstry","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0310","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00436-003-0863-0","article-title":"Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes","volume":"91","author":"Meaney","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0315","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00436-003-1036-x","article-title":"Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon","volume":"92","author":"Meaney","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00436-004-1272-8","article-title":"Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica","volume":"95","author":"Meaney","year":"2005","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00436-006-0222-z","article-title":"Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke","volume":"99","author":"Meaney","year":"2006","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0330","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00436-006-0378-6","article-title":"Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke","volume":"100","author":"Meaney","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0335","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1017\/S0031182013000759","article-title":"Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil","volume":"140","author":"Meaney","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0340","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molbiopara.2009.04.007","article-title":"Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility","volume":"167","author":"Messerli","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0345","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s004360050673","article-title":"Effects of the multidrug-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds","volume":"85","author":"Molento","year":"1999","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0350","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1645\/GE-922R.1","article-title":"Resistance-induced changes in triclabendazole transport in Fasciola hepatica: Ivermectin reversal effect","volume":"6","author":"Mottier","year":"2006","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exppara.2005.12.004","article-title":"Drug transport in helminth parasites: passive diffusion of benzimidazole anthelmintics","volume":"113","author":"Mottier","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0360","first-page":"154","article-title":"Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes","volume":"23","author":"Newton","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.exppara.2013.09.015_b0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0022149X09344934","article-title":"Adult triclabendazole-resistant Fasciola hepatica: morphological responses to in vivo treatment with artemether in the rat model","volume":"83","author":"O\u2019Neill","year":"2009","journal-title":"J. Helminthol."},{"key":"10.1016\/j.exppara.2013.09.015_b0370","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.exppara.2013.09.015_b0375","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S0031182007000091","article-title":"ABC transporters and \u03b2-tubulin in macrocyclic lactone resistance: prospects for marker development","volume":"134","author":"Prichard","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0380","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0014-4894(75)90050-8","article-title":"Electron microscope studies of Fasciola hepatica. XII. The fine structure of the gastrodermis","volume":"37","author":"Robinson","year":"1975","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0385","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S003118200100124X","article-title":"Triclabendazole-resistant Fasciola hepatica: \u00df-tubulin and response to in vitro treatment with triclabendazole","volume":"124","author":"Robinson","year":"2002","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0390","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-003-1003-6","article-title":"The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica","volume":"92","author":"Robinson","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0395","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0014-4894(84)90098-5","article-title":"Fasciola hepatica: tegumental alterations as a consequence of lectin binding","volume":"57","author":"Rogan","year":"1984","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molbiopara.2008.02.001","article-title":"Fasciola hepatica expresses multiple \u03b1- and \u03b2-tubulin isotypes","volume":"159","author":"Ryan","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2746\/0425164054530669","article-title":"Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses","volume":"37","author":"S\u00e1nchez-Bruni","year":"2005","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.exppara.2013.09.015_b0410","unstructured":"Savage, J., 2010. Studies on the mechanism of resistance to triclabendazole in the liver fluke, Fasciola hepatica. Ph.D Thesis, The Queen\u2019s University of Belfast."},{"key":"10.1016\/j.exppara.2013.09.015_b0415","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetpar.2013.03.007","article-title":"Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica","volume":"195","author":"Savage","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00930821","article-title":"The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica","volume":"76","author":"Skuce","year":"1990","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0425","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00536028","article-title":"The interaction between the deacetylated (amine) metabolite of diamphenethide (DAMD) and cytochemically demonstrable Na+\/K+-ATPase activity in the tegument of Fasciola hepatica","volume":"74","author":"Skuce","year":"1987","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0430","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1645\/0022-3395(2002)088[0612:LOPGMI]2.0.CO;2","article-title":"Localization of P-glycoprotein mRNA in the tissues of Haemonchus contortus adult worms and its relative abundance in drug-selected and susceptible strains","volume":"88","author":"Smith","year":"2002","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0435","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF00932235","article-title":"Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (\u2018Fasinex\u2019)","volume":"79","author":"Stitt","year":"1993","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0440","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0031182000077428","article-title":"The effect of the sulphoxide metabolite of triclabendazole (\u2018Fasinex\u2019) on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica","volume":"108","author":"Stitt","year":"1994","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.exppara.2011.06.018","article-title":"ABC transporters influence sensitivity of Brugia malayi to moxidectin and have potential roles in drug resistance","volume":"129","author":"Stitt","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0450","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00436-011-2378-4","article-title":"The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity","volume":"109","author":"Tompkins","year":"2011","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0455","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1017\/S0031182009005642","article-title":"A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica","volume":"136","author":"Toner","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0460","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0031182009991247","article-title":"A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica","volume":"137","author":"Toner","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2013.09.015_b0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1043-6618(03)00158-0","article-title":"P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement","volume":"48","author":"Varma","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0470","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00436-004-1222-5","article-title":"Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro","volume":"94","author":"Walker","year":"2004","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2013.09.015_b0475","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/AAC.46.1.160-165.2002","article-title":"Interaction of common azole antifungals with P glycoprotein","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2013.09.015_b0480","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1124\/dmd.32.2.172","article-title":"Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein\/CYP3A-limited bioavailability in the monkey","volume":"32","author":"Ward","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.exppara.2013.09.015_b0485","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molbiopara.2012.08.008","article-title":"An amino acid substitution in a Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations","volume":"186","author":"Wilkinson","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0490","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0166-6851(97)00215-6","article-title":"Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog","volume":"91","author":"Xu","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2013.09.015_b0495","first-page":"476","article-title":"Reversal of chloroquine resistance in falciparum malaria independent of calcium channels","volume":"30","author":"Ye","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exppara.2013.09.015_b0500","first-page":"246","article-title":"Effects of ketoconazole on the intestinal metabolism, transport and oral bioavailability of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor and a P450 3A, P-glycoprotein dual substrate, in male Sprague\u2013Dawley rats","volume":"287","author":"Zhang","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exppara.2013.09.015_b0505","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmb.2004.09.052","article-title":"Expression analysis of ABC transporters reveals differential functions of tandemly duplicated genes in Caenorhabditis elegans","volume":"344","author":"Zhao","year":"2004","journal-title":"J. Mol. Biol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413002609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489413002609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T09:45:15Z","timestamp":1572255915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489413002609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0014489413002609"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2013.09.015","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2013.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}